Skip to content
Trial Eligibility
Menu

Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes

NCT05277025

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Fibromyalgia (FM) is a chronic musculoskeletal pain disorder that afflicts up to 4% of the general population. The evaluation of pain mechanisms in FM has shown predominant central abnormalities and therefore has been designated as nociplastic pain syndrome. Rheumatoid arthritis (RA) is characterized by polyarthritis and pain from inflamed tissues, consistent with nociceptive pain. FM and RA patients may utilize overlapping pain mechanisms resulting in nociceptive and nociplastic pain.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Fibromyalgia
  • Rheumatoid Arthritis

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 70 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Florida
Last updated on ClinicalTrials.gov
August 19, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Florida · 1

  • University of Florida · Gainesville, FL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.